InvestorsHub Logo
Followers 20
Posts 2137
Boards Moderated 0
Alias Born 02/20/2013

Re: None

Tuesday, 07/26/2016 9:27:39 AM

Tuesday, July 26, 2016 9:27:39 AM

Post# of 1716
Diagnostic Performance of Urinary EGFR Testing in Lung Cancer Patients Published in Journal of Thoracic Oncology
[PR Newswire]
July 26, 2016

SAN DIEGO, July 26, 2016 /PRNewswire/ -- Trovagene, Inc. (TROV), a developer of circulating tumor DNA (ctDNA) molecular diagnostics, today announced the publication of study results that demonstrate the clinical and analytical validity of the Trovera™ urine- and blood based liquid biopsy tests to assess EGFR T790M mutational status http://www.jto.org/article/S1556-0864(16)30587-1/abstract
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDF News